Life science News and Research

RSS

Margaret Foti receives inaugural AACR award for cancer research

The Board of Directors of the American Association for Cancer Research is pleased to honor Margaret Foti, Ph.D., M.D. (h.c.) with the first annual AACR Award for Leadership and Extraordinary Achievements in Cancer Research.

12 Apr 2007

Pittsburgh Tissue Engineering Initiative awarded $1.25 million grant

The Pittsburgh Tissue Engineering Initiative, Inc. (PTEI) has been awarded a five-year grant from the National Institutes of Health (NIH) to develop a unique educational program focused on engaging middle school students, their teachers, and the general public in the wonders of tissue engineering and its applications.

12 Apr 2007

Roche to acquire BioVeris

BioVeris Corporation has announced that the Company has reached a definitive agreement under which Roche will acquire BioVeris for $21.50 per share in cash, or a total of approximately $600 million.

From Roche Sequencing and Life Science 5 Apr 2007

Some institutional review board members have ties to Rx, medical device firms

About 15% of institutional review board members, who are charged with deciding whether proposed clinical trials are ethical and safe, in the past year were asked to judge at least one proposal involving a drug or medical device company in which they have a financial stake or involving one of those company's competitors, according to a survey published in the New England Journal of Medicine

2 Dec 2006

Further European investment in genomics

The Economic and Social Research Council (ESRC) has announced continued funding, from 2007 to 2012, for its three research centres, CESAGen, EGENIS and INNOGEN, that, along with the ESRC Genomics Policy and Research Forum, make up the ESRC Genomics Network.

23 Oct 2006

New novel protein-genome interaction mapping technology

Fred Hutchinson Cancer Research Center, The Netherlands Cancer Institute (NKI) and Cancer Research Technology Limited (CRT) today have released details of the development and commercialisation of a powerful protein-genome interaction mapping technology termed 'DamID.'

14 Aug 2006

SRU Biosystems OK'd to conduct business

SRU Biosystems announces the United States District Court for the District of Delaware has resolved in SRU's favor a dispute over the content and scope of a permanent injunction order sought by Corning.

2 Aug 2006

Evotec sells single molecule detection technology to Olympus

Evotec AG has announced that its Tools and Technologies Division has sold the core of its Single Molecule Detection Technology and transferred or licensed the corresponding IP portfolio to Olympus Corporation, Tokyo, Japan.

From Evident Corporation - Life Sciences 24 Jul 2006

SRU Biosystems awarded new U.S. patent

SRU Biosystems has announced that U.S. Patent 7,070,987 (the '987 patent), entitled "Guided mode resonant filter biosensor using a linear grating surface structure" was issued to SRU Biosystems, Inc. on July 4, 2006.

10 Jul 2006

Peptide for myocardial infarction proves to be safe

FIBREX Medical has successfully completed a first dose in man study with its lead product, the anti-inflammatory peptide FX06.

6 Apr 2006

RNAi-based inhibitors for created for nearly every human and mouse gene - available to all genetic researchers

An international public-private research team led by scientists at the Broad Institute of MIT and Harvard announced today the construction and availability of an extensive library of molecular reagents to silence most human and mouse genes.

28 Mar 2006

Menin is a key player in the development of some forms of acute leukemia

Tumor-suppressor proteins work to inhibit tumor growth in our bodies and when they win, they spare us a battle with cancer. But one such protein, menin, appears to have a split personality.

20 Oct 2005

New study of the public's priorities for the funding of research into what people eat and how it affects their health

The study, conducted by MORI Social Research Institute, explores any differences between the agendas of the public and research funders at a time when the health implications of the food that we consume have a very high profile. The study was commissioned by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Institute of Food Research (IFR), who will consider the results as part of their strategic planning for future funding.

12 Oct 2005

Curry spice may help fight oesophageal cancer

Welsh researchers apparently believe a spice used in curry may possibly prevent people from developing cancer of the gullet.

10 Aug 2005

Pedometers motivate walkers

Need motivation to walk 10,000 steps? Get a pedometer, says University of Tennessee professor Dixie Lee Thompson.

2 Aug 2005

Sigma-Aldrich licenses RNAi patent estate from Alnylam

Sigma-Aldrich Corporation and Alnylam Pharmaceuticals announced today that Alnylam has granted Sigma-Aldrich a non-exclusive license to provide research products and services in RNA interference (RNAi) under the Kreutzer-Limmer patent family.

19 Jul 2005

Australian scientists develop unique animal model for asthma

The State Government of Victoria, Australia has announced that Melbourne veterinary scientists have developed a unique animal model for asthma that may help drug companies fast track the creation of therapies for the disease.

19 Jun 2005

Future out-licensing of BioSilicon in tissue engineering and orthopedics

Global nanotechnology company pSivida Limited has announced that it has signed an agreement with US based PureTech Development LLC to investigate and evaluate out-licensing opportunities for BioSilicon with an emphasis on tissue engineering, wound management and orthopedics.

28 Feb 2005

Startling results from new biomedical research will smooth path to the market place

Researchers have discovered how to convert liver cells of mice into pancreatic cells using a single injection. This may eventually lead to a cure for diabetes. Dr. James Mittra, one of the organisers of an international conference in Edinburgh on the Evolution of the Life Science Industries asks, “How does the pharmaceutical industry respond to this kind of work? They are primarily interested in treatments, not cures. Do they see this kind of research as a threat?”

27 Jan 2005

Study finds new method can improve chemo survival

Seeking to find a way to lessen patients’ vulnerability to deadly infections following chemotherapy, researchers at the Stanford University School of Medicine have figured out a way to boost the immune function in animals following such treatments.

21 Dec 2004